Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia

被引：7
|
作者：
Wei, Hui [1 ,2 ,3 ,4 ]
Zhou, Chunlin [3 ,4 ]
Lin, Dong [3 ,4 ]
Liu, Bingcheng [3 ,4 ]
Li, Yan [3 ,4 ]
Zhao, Xingli [3 ,4 ]
Wei, Shuning [3 ,4 ]
Gong, Benfa [3 ,4 ]
Liu, Kaiqi [3 ,4 ]
Gong, Xiaoyuan [3 ,4 ]
Liu, Yuntao [3 ,4 ]
Zhang, Guangji [3 ,4 ]
Chen, Jiayuan [1 ]
Zhang, Junping [3 ,4 ]
Jin, Jingjing [3 ,4 ]
Qiu, Shaowei [3 ,4 ]
Gu, Runxia [3 ,4 ]
Wang, Ying [2 ,3 ,4 ]
Mi, Yingchan [1 ,2 ,3 ,4 ]
Wang, Jianxiang [1 ,2 ,3 ,4 ]
机构：
[1] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Inst Hematol, Natl Clin Res Ctr Blood Dis, Tianjin, Peoples R China
[3] Chinese Acad Med Sci, Inst Hematol, Leukemia Ctr, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 05期
基金：
中国国家自然科学基金;
关键词：
RANDOMIZED-TRIAL; ADULTS; DAUNORUBICIN; AML;
D O I：
10.3324/haematol.2020.267526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1491 / 1495
页数：5
相关论文
共 50 条
  • [1] Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia
    Wei, Hui
    Wang, Ying
    Gale, Robert Peter
    Lin, Dong
    Zhou, Chunlin
    Liu, Bingcheng
    Qiu, Shaowei
    Gu, Runxia
    Li, Yan
    Zhao, Xingli
    Wei, Shuning
    Gong, Benfa
    Liu, Kaiqi
    Gong, Xiaoyuan
    Liu, Yuntao
    Zhang, Guangji
    Song, Zhen
    Wang, Yang
    Li, Wei
    Mi, Yingchang
    Wang, Jianxiang
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3154 - 3161
  • [2] TREATMENT OF RELAPSED ACUTE MYELOID-LEUKEMIA WITH IDARUBICIN AND INTERMEDIATE-DOSE CYTARABINE
    HAROUSSEAU, JL
    REIFFERS, J
    HURTELOUP, P
    MILPIED, N
    GUY, H
    RIGALHUGUET, F
    FACON, T
    DUFOUR, P
    IFRAH, N
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 45 - 49
  • [3] Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia
    Sutoh, H
    Yamauchi, T
    Gotoh, N
    Sugiyama, M
    Ueda, T
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5037 - 5042
  • [4] Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?
    Bertoli, Sarah
    Gadaud, Noemie
    Tavitian, Suzanne
    Sarry, Audrey
    Berard, Emilie
    Huguet, Francoise
    Recher, Christian
    BLOOD, 2016, 128 (22)
  • [5] Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia
    Li, Wenhui
    Richter, Katherine
    Lee, Jamie
    McCarthy, Kevin
    Kubal, Timothy
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1812 - 1818
  • [6] Induction and consolidation therapy with intermediate-dose cytarabine, mitoxantrone and etoposide in patients >=60 years with acute myeloid leukemia (AML).
    Shepherd, JD
    Barnett, MJ
    Brockington, DA
    Fung, HC
    Klingemann, HG
    Nantel, SH
    Reece, DE
    Sutherland, HJ
    Thierman, JG
    Toze, CL
    Phillips, GL
    BLOOD, 1995, 86 (10) : 2075 - 2075
  • [7] High-dose mercaptopurine and intermediate-dose cytarabine during first remission of acute myeloid leukemia
    Canpolat, C
    Jeha, S
    Lockhart, S
    Ramirez, I
    Zipf, T
    Pinkel, D
    CANCER INVESTIGATION, 1997, 15 (02) : 121 - 126
  • [8] Mitoxantrone and Etoposide with or without Intermediate-Dose Cytarabine for the Treatment of Patients with Primary Induction Failure or Relapsed Acute Myeloid Leukemia
    Trifilio, Steven
    Radamaker, Alfred
    Newman, Diane
    Coyle, Kathryn
    Leuer, Katrin Carlson
    Mehta, Jayesh
    Altman, Jessica Kaplan
    Frankfurt, Olga
    Tallman, Martin S.
    BLOOD, 2010, 116 (21) : 897 - 898
  • [9] Intensified Induction Chemotherapy with Regimen Containing Intermediate Dose Cytarabine for De Novo Acute Myeloid Leukemia
    Wang, Jianxiang
    Mi, Yingchang
    Liu, Jiazhuo
    Fu, Mingwei
    Wang, Ying
    Lin, Dong
    Bian, Shougeng
    BLOOD, 2008, 112 (11) : 348 - 348
  • [10] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Dae Sik Kim
    Ka-Won Kang
    Se Ryeon Lee
    Yong Park
    Hwa Jung Sung
    Seok Jin Kim
    Chul Won Choi
    Byung Soo Kim
    Annals of Hematology, 2015, 94 : 1485 - 1492
12345